Genomic profiling of pediatric tumors after relapse may widen treatment options
Genomic sequencing of tumors enabled 107 patients with pediatric cancer who experienced relapse to receive an appropriate matched therapy that is not standard of care, according to study results reported in Cancer Discovery. The international MAPPYACTS precision medicine clinical trial sought to use results of genetic profiling of tumors to suggest treatments targeted to molecular alterations.